IDR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IDR is not a clear buy right now for a beginner long-term investor, even with $50,000-$100,000 available. The company has very strong recent financial growth and supportive mineral-sector news, but the current technical picture is mixed and there is no proprietary buy signal today. My direct view: wait rather than buy immediately.
The trend is constructive but not ideal for an immediate entry. Price is trading in pre-market around 42.79, slightly below the pivot at 43.113 and below the first resistance at 46.1. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, which supports the broader uptrend. However, MACD histogram is negative and expanding, showing short-term momentum is weakening. RSI_6 at 54.01 is neutral, so the stock is not oversold or strongly overbought. Overall, the chart shows an uptrend with near-term hesitation.
["Strong Q4 2025 financial growth: revenue up 92.02% YoY, net income up 274.07% YoY, EPS up 227.78% YoY, and gross margin up 28.67% YoY.", "Macro and industry news is favorable for strategic minerals: the US is emphasizing critical mineral security.", "Tungsten processing prices have surged sharply due to Chinese export controls, which can support mining-related names with strategic mineral exposure.", "The silver market remains in a long-running supply deficit, which is supportive for resource producers.", "Technical structure remains bullish on medium- to long-term moving averages."]
["MACD histogram is negative and worsening, suggesting near-term momentum deterioration.", "Price is below the pivot and still needs to reclaim higher resistance levels to confirm stronger breakout strength.", "No AI Stock Picker signal today.", "No SwingMax entry signal recently.", "Hedge funds and insiders are both neutral, so there is no strong institutional or insider buying support.", "No recent congress trading data is available.", "Similar-pattern trend analysis suggests weak near-term performance expectations."]
Latest reported quarter: 2025/Q4. Financial performance was very strong, with revenue increasing to 14,569,706, up 92.02% year over year. Net income rose to 9,364,679, up 274.07% YoY. EPS improved to 0.59, up 227.78% YoY. Gross margin expanded to 68.53, up 28.67% YoY. This is an excellent growth quarter and clearly supports the long-term story.
No analyst rating or price target change data was provided, so there is no visible recent Wall Street consensus trend to summarize. Based on the available information, Wall Street pros would likely see the stock as fundamentally improving because of the strong financial growth and favorable sector backdrop, but the cons view would focus on the lack of a current proprietary buy signal, the negative short-term MACD, and the absence of clear institutional accumulation data.
